This barrier is unrelated to the end of the transition period, following the United Kingdom's departure from the EU.

Public ID: PID-GRL48G

Prescription restrictions on new pharmaceuticals in Japan affecting UK exporters and investors

in Japan

Trade barrier summary

In Japan, restrictions placed on new pharmaceuticals limit prescription periods to 14 days during the first year the pharmaceutical is on the market. This restriction exists even though new pharmaceuticals have gone through approval processes.

UK businesses are concerned that this restriction may limit patient access to innovative medicines. It could also mean that Japanese doctors are less likely to prescribe these pharmaceuticals.

Sectors affected

  • Pharmaceuticals and biotechnology



Date reported

13 November 2018

Last updated

17 December 2020

Public ID


Back to search results

If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .

If you export goods you can check duties and customs procedures for your chosen market.